Literature DB >> 30935565

Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning.

José Marcio Luna1, Hann-Hsiang Chao2, Eric S Diffenderfer2, Gilmer Valdes3, Chidambaram Chinniah4, Grace Ma2, Keith A Cengel2, Timothy D Solberg3, Abigail T Berman2, Charles B Simone5.   

Abstract

BACKGROUND AND
PURPOSE: Radiation pneumonitis (RP) is a radiotherapy dose-limiting toxicity for locally advanced non-small cell lung cancer (LA-NSCLC). Prior studies have proposed relevant dosimetric constraints to limit this toxicity. Using machine learning algorithms, we performed analyses of contributing factors in the development of RP to uncover previously unidentified criteria and elucidate the relative importance of individual factors.
MATERIALS AND METHODS: We evaluated 32 clinical features per patient in a cohort of 203 stage II-III LA-NSCLC patients treated with definitive chemoradiation to a median dose of 66.6 Gy in 1.8 Gy daily fractions at our institution from 2008 to 2016. Of this cohort, 17.7% of patients developed grade ≥2 RP. Univariate analysis was performed using trained decision stumps to individually analyze statistically significant predictors of RP and perform feature selection. Applying Random Forest, we performed multivariate analysis to assess the combined performance of important predictors of RP.
RESULTS: On univariate analysis, lung V20, lung mean, lung V10 and lung V5 were found to be significant RP predictors with the greatest balance of specificity and sensitivity. On multivariate analysis, Random Forest (AUC = 0.66, p = 0.0005) identified esophagus max (20.5%), lung V20 (16.4%), lung mean (15.7%) and pack-year (14.9%) as the most common primary differentiators of RP.
CONCLUSIONS: We highlight Random Forest as an accurate machine learning method to identify known and new predictors of symptomatic RP. Furthermore, this analysis confirms the importance of lung V20, lung mean and pack-year as predictors of RP while also introducing esophagus max as an important RP predictor.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CART; Logistic regression; Machine learning; Non-small cell lung cancer; RUSBoost; Radiation pneumonitis; Random forest; Support vector machines

Mesh:

Year:  2019        PMID: 30935565     DOI: 10.1016/j.radonc.2019.01.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  20 in total

1.  Prediction of radiation pneumonitis with machine learning using 4D-CT based dose-function features.

Authors:  Yoshiyuki Katsuta; Noriyuki Kadoya; Shina Mouri; Shohei Tanaka; Takayuki Kanai; Kazuya Takeda; Takaya Yamamoto; Kengo Ito; Tomohiro Kajikawa; Yujiro Nakajima; Keiichi Jingu
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

2.  Feasibility of Differential Dose-Volume Histogram Features in Multivariate Prediction Model for Radiation Pneumonitis Occurrence.

Authors:  Yoshiyuki Katsuta; Noriyuki Kadoya; Yuto Sugai; Yu Katagiri; Takaya Yamamoto; Kazuya Takeda; Shohei Tanaka; Keiichi Jingu
Journal:  Diagnostics (Basel)       Date:  2022-05-31

3.  Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.

Authors:  Narek Shaverdian; Michael D Offin; Andreas Rimner; Annemarie F Shepherd; Abraham J Wu; Charles M Rudin; Matthew D Hellmann; Jamie E Chaft; Daniel R Gomez
Journal:  Radiother Oncol       Date:  2019-11-28       Impact factor: 6.280

Review 4.  Artificial intelligence and machine learning for medical imaging: A technology review.

Authors:  Ana Barragán-Montero; Umair Javaid; Gilmer Valdés; Dan Nguyen; Paul Desbordes; Benoit Macq; Siri Willems; Liesbeth Vandewinckele; Mats Holmström; Fredrik Löfman; Steven Michiels; Kevin Souris; Edmond Sterpin; John A Lee
Journal:  Phys Med       Date:  2021-05-09       Impact factor: 2.685

5.  Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy.

Authors:  Annemarie F Shepherd; Michelle Iocolano; Jonathan Leeman; Brandon S Imber; Aaron T Wild; Michael Offin; Jamie E Chaft; James Huang; Andreas Rimner; Abraham J Wu; Daphna Y Gelblum; Narek Shaverdian; Charles B Simone; Daniel R Gomez; Ellen D Yorke; Andrew Jackson
Journal:  Pract Radiat Oncol       Date:  2020-10-14

6.  A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy.

Authors:  Wenjie Tang; Xiaolin Li; Haining Yu; Xiaoyang Yin; Bing Zou; Tingting Zhang; Jinlong Chen; Xindong Sun; Naifu Liu; Jinming Yu; Peng Xie
Journal:  BMC Cancer       Date:  2021-05-22       Impact factor: 4.430

7.  Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation.

Authors:  José Marcio Luna; Hann-Hsiang Chao; Russel T Shinohara; Lyle H Ungar; Keith A Cengel; Daniel A Pryma; Chidambaram Chinniah; Abigail T Berman; Sharyn I Katz; Despina Kontos; Charles B Simone; Eric S Diffenderfer
Journal:  Clin Transl Radiat Oncol       Date:  2020-03-24

8.  Analyzing oropharyngeal cancer survival outcomes: a decision tree approach.

Authors:  Francesca De Felice; Laia Humbert-Vidan; Mary Lei; Andrew King; Teresa Guerrero Urbano
Journal:  Br J Radiol       Date:  2020-05-21       Impact factor: 3.039

9.  Building more accurate decision trees with the additive tree.

Authors:  José Marcio Luna; Efstathios D Gennatas; Lyle H Ungar; Eric Eaton; Eric S Diffenderfer; Shane T Jensen; Charles B Simone; Jerome H Friedman; Timothy D Solberg; Gilmer Valdes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

10.  Identifying Lung Cancer Risk Factors in the Elderly Using Deep Neural Networks: Quantitative Analysis of Web-Based Survey Data.

Authors:  Songjing Chen; Sizhu Wu
Journal:  J Med Internet Res       Date:  2020-03-17       Impact factor: 7.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.